269 related articles for article (PubMed ID: 35280291)
1. Temporal Progression Patterns of Brain Atrophy in Corticobasal Syndrome and Progressive Supranuclear Palsy Revealed by Subtype and Stage Inference (SuStaIn).
Saito Y; Kamagata K; Wijeratne PA; Andica C; Uchida W; Takabayashi K; Fujita S; Akashi T; Wada A; Shimoji K; Hori M; Masutani Y; Alexander DC; Aoki S
Front Neurol; 2022; 13():814768. PubMed ID: 35280291
[TBL] [Abstract][Full Text] [Related]
2. The feasibility of white matter volume reduction analysis using SPM8 plus DARTEL for the diagnosis of patients with clinically diagnosed corticobasal syndrome and Richardson's syndrome.
Sakurai K; Imabayashi E; Tokumaru AM; Hasebe S; Murayama S; Morimoto S; Kanemaru K; Takao M; Shibamoto Y; Matsukawa N
Neuroimage Clin; 2015; 7():605-10. PubMed ID: 26082887
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome.
Jabbari E; Holland N; Chelban V; Jones PS; Lamb R; Rawlinson C; Guo T; Costantini AA; Tan MMX; Heslegrave AJ; Roncaroli F; Klein JC; Ansorge O; Allinson KSJ; Jaunmuktane Z; Holton JL; Revesz T; Warner TT; Lees AJ; Zetterberg H; Russell LL; Bocchetta M; Rohrer JD; Williams NM; Grosset DG; Burn DJ; Pavese N; Gerhard A; Kobylecki C; Leigh PN; Church A; Hu MTM; Woodside J; Houlden H; Rowe JB; Morris HR
JAMA Neurol; 2020 Mar; 77(3):377-387. PubMed ID: 31860007
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Accuracy of Magnetic Resonance Imaging Measures of Brain Atrophy Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Degeneration.
Illán-Gala I; Nigro S; VandeVrede L; Falgàs N; Heuer HW; Painous C; Compta Y; Martí MJ; Montal V; Pagonabarraga J; Kulisevsky J; Lleó A; Fortea J; Logroscino G; Quattrone A; Quattrone A; Perry DC; Gorno-Tempini ML; Rosen HJ; Grinberg LT; Spina S; La Joie R; Rabinovici GD; Miller BL; Rojas JC; Seeley WW; Boxer AL
JAMA Netw Open; 2022 Apr; 5(4):e229588. PubMed ID: 35486397
[TBL] [Abstract][Full Text] [Related]
5. Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease.
Rizzo G; Martinelli P; Manners D; Scaglione C; Tonon C; Cortelli P; Malucelli E; Capellari S; Testa C; Parchi P; Montagna P; Barbiroli B; Lodi R
Brain; 2008 Oct; 131(Pt 10):2690-700. PubMed ID: 18819991
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of progressive supranuclear palsy presenting with corticobasal syndrome: a cortical variant.
Ling H; de Silva R; Massey LA; Courtney R; Hondhamuni G; Bajaj N; Lowe J; Holton JL; Lees A; Revesz T
Neuropathol Appl Neurobiol; 2014 Feb; 40(2):149-63. PubMed ID: 23432126
[TBL] [Abstract][Full Text] [Related]
7. Intracortical diffusion tensor imaging signature of microstructural changes in frontotemporal lobar degeneration.
Torso M; Ridgway GR; Jenkinson M; Chance S;
Alzheimers Res Ther; 2021 Oct; 13(1):180. PubMed ID: 34686217
[TBL] [Abstract][Full Text] [Related]
8. Uncovering clinical and radiological asymmetry in progressive supranuclear palsy-Richardson's syndrome.
Picillo M; Tepedino MF; Abate F; Ponticorvo S; Erro R; Cuoco S; Oksuz N; Di Salle G; Di Salle F; Esposito F; Pellecchia MT; Manara R; Barone P
Neurol Sci; 2022 Jun; 43(6):3677-3682. PubMed ID: 35106692
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the Effect of Alzheimer's Disease-Related Biomarker Change in Corticobasal Syndrome and Progressive Supranuclear Palsy.
Garcia-Cordero I; Anastassiadis C; Khoja A; Morales-Rivero A; Thapa S; Vasilevskaya A; Davenport C; Sumra V; Couto B; Multani N; Taghdiri F; Anor C; Misquitta K; Vandevrede L; Heuer H; Tang-Wai D; Dickerson B; Pantelyat A; Litvan I; Boeve B; Rojas JC; Ljubenkov P; Huey E; Fox S; Kovacs GG; Boxer A; Lang A; Tartaglia MC;
Ann Neurol; 2024 Jul; 96(1):99-109. PubMed ID: 38578117
[TBL] [Abstract][Full Text] [Related]
10. Brain volume and flortaucipir analysis of progressive supranuclear palsy clinical variants.
Whitwell JL; Tosakulwong N; Botha H; Ali F; Clark HM; Duffy JR; Utianski RL; Stevens CA; Weigand SD; Schwarz CG; Senjem ML; Jack CR; Lowe VJ; Ahlskog JE; Dickson DW; Josephs KA
Neuroimage Clin; 2020; 25():102152. PubMed ID: 31935638
[TBL] [Abstract][Full Text] [Related]
11. The Significance of Asymmetry in the Assessment of Brain Perfusion in Atypical Tauopathic Parkinsonian Syndromes.
Alster P; Madetko N; Migda B; Nieciecki M; Kutyłowski M; Królicki L; Friedman A
Diagnostics (Basel); 2022 Jul; 12(7):. PubMed ID: 35885575
[TBL] [Abstract][Full Text] [Related]
12. Midbrain atrophy in patients with presymptomatic progressive supranuclear palsy-Richardson's syndrome.
Ahn JH; Kim M; Kim JS; Youn J; Jang W; Oh E; Lee PH; Koh SB; Ahn TB; Cho JW
Parkinsonism Relat Disord; 2019 Sep; 66():80-86. PubMed ID: 31307918
[TBL] [Abstract][Full Text] [Related]
13. Magnetic Susceptibility in Progressive Supranuclear Palsy Variants, Parkinson's Disease, and Corticobasal Syndrome.
Satoh R; Weigand SD; Pham NTT; Ali F; Arani A; Senjem ML; Jack CR; Whitwell JL; Josephs KA
Mov Disord; 2023 Dec; 38(12):2282-2290. PubMed ID: 37772771
[TBL] [Abstract][Full Text] [Related]
14. Uncovering spatiotemporal patterns of atrophy in progressive supranuclear palsy using unsupervised machine learning.
Scotton WJ; Shand C; Todd E; Bocchetta M; Cash DM; VandeVrede L; Heuer H; ; Young AL; Oxtoby N; Alexander DC; Rowe JB; Morris HR; Boxer AL; Rohrer JD; Wijeratne PA
Brain Commun; 2023; 5(2):fcad048. PubMed ID: 36938523
[TBL] [Abstract][Full Text] [Related]
15. Probable 4-Repeat Tauopathy Criteria Predict Brain Amyloid Negativity, Distinct Clinical Features, and FDG-PET/MRI Neurodegeneneration Patterns in Corticobasal Syndrome.
Parmera JB; de Godoi Carneiro C; de Almeida IJ; de Oliveira MCB; Barbosa PM; Studart-Neto A; Ono CR; Nitrini R; Buchpiguel CA; Barbosa ER; Brucki SMD; Coutinho AM
Mov Disord Clin Pract; 2024 Mar; 11(3):238-247. PubMed ID: 38155526
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration.
Gröschel K; Hauser TK; Luft A; Patronas N; Dichgans J; Litvan I; Schulz JB
Neuroimage; 2004 Feb; 21(2):714-24. PubMed ID: 14980574
[TBL] [Abstract][Full Text] [Related]
17. Features of Patients With Nonfluent/Agrammatic Primary Progressive Aphasia With Underlying Progressive Supranuclear Palsy Pathology or Corticobasal Degeneration.
Santos-Santos MA; Mandelli ML; Binney RJ; Ogar J; Wilson SM; Henry ML; Hubbard HI; Meese M; Attygalle S; Rosenberg L; Pakvasa M; Trojanowski JQ; Grinberg LT; Rosen H; Boxer AL; Miller BL; Seeley WW; Gorno-Tempini ML
JAMA Neurol; 2016 Jun; 73(6):733-42. PubMed ID: 27111692
[TBL] [Abstract][Full Text] [Related]
18. Midbrain atrophy is not a biomarker of progressive supranuclear palsy pathology.
Whitwell JL; Jack CR; Parisi JE; Gunter JL; Weigand SD; Boeve BF; Ahlskog JE; Petersen RC; Dickson DW; Josephs KA
Eur J Neurol; 2013 Oct; 20(10):1417-22. PubMed ID: 23746093
[TBL] [Abstract][Full Text] [Related]
19. PET Tau Imaging and Motor Impairments Differ Between Corticobasal Syndrome and Progressive Supranuclear Palsy With and Without Alzheimer's Disease Biomarkers.
Vasilevskaya A; Taghdiri F; Multani N; Anor C; Misquitta K; Houle S; Burke C; Tang-Wai D; Lang AE; Fox S; Slow E; Rusjan P; Tartaglia MC
Front Neurol; 2020; 11():574. PubMed ID: 32754109
[No Abstract] [Full Text] [Related]
20. Clinicoradiologic and Neuropathologic Evaluation of Corticobasal Syndrome.
Shir D; Pham NTT; Botha H; Koga S; Kouri N; Ali F; Knopman DS; Petersen RC; Boeve BF; Kremers WK; Nguyen AT; Murray ME; Reichard RR; Dickson DW; Graff-Radford N; Josephs KA; Whitwell J; Graff-Radford J
Neurology; 2023 Jul; 101(3):e289-e299. PubMed ID: 37268436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
